Insiders · Profile

Kelly Timothy P

Chief Technology Officer at Caribou Biosciences · Chief Operating Officer at Q32 Bio. Filing since 3 Jun 2019. CIK 0001754067

Company
Date
Role
Action
Shares
Amount
Of holding
25 Feb 2026
Chief Technology Officer
Sold at will
6,228
$12.02K
7.8%
24 Feb 2026
Chief Technology Officer
Sold at will
3,147
$6.17K
3.8%
5 Jan 2022
Chief Operating Officer
Sold, plan not stated
1,406
$5.31K
38.7%
3 Sep 2021
See Remarks.
Sold, plan not stated
54
$415.80
100%
1 Mar 2021
See Remarks.
Bought
6,232
$69.56K
opened
2 Feb 2021
See Remarks
Sold, plan not stated
500
$6.50K
100%
1 Feb 2021
See Remarks
Sold, plan not stated
4,000
$49.46K
100%
12 Jan 2021
See Remarks
Sold, plan not stated
500
$6.50K
100%
4 Jan 2021
See Remarks
Sold, plan not stated
4,000
$45.98K
100%
17 Mar 2020
See Remarks
Sold, plan not stated
1,315
$17.11K
100%
5 Sep 2019
See Remarks
Sold, plan not stated
1,166
$23.25K
100%
3 Jun 2019
See Remarks
Sold, plan not stated
1,288
$25.76K
100%
12 decisions on file.